+97.1%
GSK vs DAR
+271.1%
-174.1%
-37.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 10y.
| Period | Portfolio | DAR | Excess | Alpha |
|---|---|---|---|---|
| 1D | -0.1% | -2.7% | +2.5% | +0.2% |
| 7D | -5.3% | -9.6% | +4.3% | -4.3% |
| 30D | -3.7% | -14.3% | +10.7% | -2.2% |
| 3M | -7.3% | -25.4% | +18.1% | -4.6% |
| 6M | -4.2% | -14.2% | +9.9% | -3.2% |
| YTD | +0.9% | +40.6% | -39.7% | -4.1% |
| 1Y | +7.3% | +57.5% | -50.3% | +0.6% |
| 3Y | +52.7% | +16.3% | +36.4% | +45.4% |
| 5Y | +40.1% | -29.1% | +69.3% | +39.8% |
| All | +97.1% | +271.1% | -174.1% | +41.8% |
Cumulative growth
Daily Returns
Daily percentage return beside DAR.
Daily Out/Under-Performance
Portfolio return minus DAR return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × DAR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 10y: compounded portfolio wealth divided by compounded DAR wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
10y analysis · Full analysis span regression · 6 months rolling